Venture Investing at the Earliest Stage


 

CommonwealthPacific Ventures ("CPV") was formed in 1999 as a vehicle for evaluating, advising, and investing in early stage companies and real estate opportunities in New England and California.  CPV is not a fund, rather is the private equity of its founders.  As such, CPV often takes an active role in the companies in which it invests, providing mentoring and advice, and often a day-to-day role. 

CPV will evaluate executive summaries of business plans in most fields, although our particular interests include life-sciences, energy and environment, web-based tools, community-focused investment, and women-owned businesses.  Interested entrepreneurs are encouraged to contact us.

To date, CPV has provided capital to 7 companies.  Our portfolio is limited to no more than 3 or 4 companies at a time, with our "active" role targeted to no more than 2.  CPV has provided both equity and lending to companies.  Typically, each transaction is under $500,000.  The goal is to exit each company in a three year timeframe.

Example Investments:

  • Pharmaceutical Tools Company --  Massachusetts.   Provides nanoscale liquid delivery for drug discovery through its PocketTips product.  PocketTips effectively manage sub-microliter fluid volumes, regardless of the pipettor used.  Dispensing precision and accuracy are achieved through capillary metering and integral dilution.  Customers include large and small pharmaceutical and biotechs.  CPV coordinated and participated in the initial round of funding, raising $600,000 in June 2004.  Additional lending of $250,000 during life of the Company.  Company was sold to Thermo Fisher Scientific in December 2007. 
  • Poultry Genetics Company -- Connecticut.  A poultry genetics company that produces breeding stock for the $60 billion global broiler market.  The company has developed pedigree lines based on a drug-free production platform, eliminating the need for antibiotics and growth promotants.  This reduces costs of production, but meets the increasing demand for "healthy" poultry products.  In 2002, CPV provided lending and initial equity in the Company.  The Company received second round venture capital financing in June 2004 and was acquired in 2008. 
  • Employee Management Software Company -- Massachusetts.  This software start-up is developing tools to assist employers and staff of companies that rely on an hourly labor pool.  Investment was made in December 2007. 
  • Community Bank -- Massachusetts.  CPV participated in the initial funding of a community bank in 2009.  The bank will focus on community-based lending and retail services.

CPV's Principals are David Stoldt and Constance Wright.  From 2005 until its sale in December 2007, Mr. Stoldt was President and CEO of nAscent BioSciences, a CPV funded start-up.  In addition to the roles he has served for CPV companies since 2000, Mr. Stoldt previously spent 13 years in the investment banking field providing underwriting and financial advisory services to private companies and public agencies.  He has been an elected official, coached youth sports, and has served on various boards of organizations, non-profits, and small companies.  Mr. Stoldt received an MBA from Stanford, an MS from University of California, Berkeley and a BS in engineering from University of Illinois.

Constance S. Wright is a Managing Director with a Boston-region financial services and consulting company.  Clients served typically include Fortune 500 companies with high-level needs.  She was formerly the Director of the New England practice of Resources, a national publicly-traded (RECN) company providing interim support staffing for accounting and financial projects.  Connie also serves as a board member of the Center for Women in Enterprise, a non-profit assisting business formation by women.  She earned her CPA in 1987 and is a graduate of Stanford University.  CPV's principals were early-stage investors in RECN.

94 Saddle Hill Road, Hopkinton, MA 01748

dstoldt@commonwealthpacific.com